Emetine

CHEMBL50588 Phase 4 Onaylandı Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
480.6 g/mol
LogP
4.7
Phase
4

This alkaloid compound has antiparasitic and antiamebic properties and has historically been used to treat infections caused by amoeba. It has also been studied for potential anticancer effects in laboratory settings.

Moleküler Ağırlık

480,6000 g/mol

LogP

4,70

TPSA

52,20 Ų

Lipinski RO5

Geçer

Etki Mekanizması

Disrupts essential metabolic pathways or structural components of parasitic organisms, leading to paralysis, starvation, or death of the parasite.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mekanizma

Disrupts essential metabolic pathways or structural components of parasitic organisms, leading to paralysis, starvation, or death of the parasite.

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21

InChI

InChI=1S/C29H40N2O4/c1-6-18-17-31-10-8-20-14-27(33-3)29(35-5)16-23(20)25(31)12-21(18)11-24-22-15-28(34-4)26(32-2)13-19(22)7-9-30-24/h13-16,18,21,24-25,30H,6-12,17H2,1-5H3/t18-,21-,24+,25-/m0/s1

Molecular Formula

C29H40N2O4

HBD / HBA

1 / 6

Döndürülebilir Bağlar

7

Ağır Atomlar

35

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

This alkaloid compound has antiparasitic and antiamebic properties and has historically been used to treat infections caused by amoeba. It has also been studied for potential anticancer effects in laboratory settings.

Disrupts essential metabolic pathways or structural components of parasitic organisms, leading to paralysis, starvation, or death of the parasite.

Yes, Emetine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL50588. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 10219. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.